Qnasl — Class III drug recall D-0171-2017
Terminated recall by Teva Pharmaceuticals USA, reported 2016-12-14, distributed nationwide. Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stabi
| Recall number | D-0171-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2016-11-01 |
| Classified | 2016-12-08 |
| Reported by FDA | 2016-12-14 |
| Terminated | 2018-02-06 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 59310-0210-13 |
| Lot numbers | 150335, 150336 |
| Expiration dates | 2017-04 |
Product
Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.
Reason for recall
Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0171-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.